文献速递慢性静脉疾病

新型双模式动态压迫装置治疗慢性静脉性腿溃疡的经济效益:随机临床试验

Economic benefit of a novel dual-mode ambulatory compression device for treatment of chronic venous leg ulcers in a randomized clinical trial.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-05-22

该前瞻性随机临床试验将56例慢性静脉性腿溃疡患者随机分配至新型动态气压压迫装置组或多层绷带压迫组,因装置耐受性问题提前终止。可耐受并完成16周治疗的患者中,两组愈合率相似,但装置组溃疡面积缩小百分比更高。

要点

  • 新型动态气压压迫装置在可耐受患者中愈合效果与多层绷带相似。
  • 装置组因皮肤或伤口问题及使用不便导致较多退出,试验提前终止。
  • 装置组溃疡面积缩小百分比高于多层绷带组,但愈合率无显著差异。

核心结论

  • 在提前终止的临床试验中,新型双模式动态压迫装置在可耐受时对慢性静脉性腿溃疡的愈合效果与多层绷带相似。

研究设计与样本

  • 前瞻性随机临床试验,计划纳入静脉性腿溃疡面积1.5至50 cm²、病程1至24个月的患者,随机分配至ACT装置组或多层绷带组。
  • 实际随机56例,ACT组26例,多层绷带组30例;因装置相关皮肤或伤口问题及使用不便导致退出,试验提前终止。

主要发现

  • 符合方案完成16周治疗的42例患者中,两组愈合率相似,ACT组为60.0%,多层绷带组为63.0%。
  • 符合方案人群中,ACT组溃疡面积缩小百分比为83.8%,多层绷带组为70.5%。

临床怎么用

  • 对于可耐受新型双模式动态压迫装置的慢性静脉性腿溃疡患者,该装置可作为多层绷带压迫的替代选择。
  • 使用中需关注皮肤或伤口相关问题及使用不便导致的退出。

局限性

  • 试验因装置耐受性问题提前终止,样本量小,未完成完整随机化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limb compression is a key component of protocols used to heal venous leg ulcers (VLUs). A novel ambulatory pneumatic compression device was tested in comparison with multilayered bandage (MLB) compression systems for the treatment of VLUs in a prospective randomized clinical trial. METHODS: Patients with VLUs measuring 1.5 to 50 cm2 with duration of 1 to 24 months were randomized to treatment with a pneumatic compression device, the ACTitouch adaptive compression therapy (ACT) system (Tactile Medical, Minneapolis, Minn), or MLB. The ACT group patients were seen in the clinic at weeks 1, 2, 4, 6, 9, 12, and 16 or until wounds healed; the MLB group was seen weekly for bandage and dressing changes for 16 weeks or until wounds healed. All other aspects of VLU care were standardized between the two groups. The primary study objective was to compare the VLU percentage area reduction at 16 weeks in the ACT group compared with the MLB group. RESULTS: There were 56 patients randomized to treatment with ACT (n = 26) or MLB (n = 30). In the ACT group, five patients exited because of skin or wound problems related to the ACT device and five withdrew because of the inconvenience of using the device. Therefore, the trial was halted before full randomization so improvements to the ACT device could be made. Data collected on 42 patients who were able to tolerate treatment for the 16-week study period (per protocol group) showed that both groups experienced similar rates of wound healing. In the per protocol population, the percentage area size reduction was greater for the ACT group compared with the MLB group (83.8% vs 70.5%, respectively), whereas no significant differences were noted in the percentage of wounds that healed by 16 weeks (60.0% vs 63.0%, respectively). CONCLUSIONS: In this truncated clinical trial, a novel dual-mode ambulatory compression device, when tolerated, achieved wound healing results similar to those with MLB for chronic VLUs. The device requires modifications to improve the patient's comfort and ease of use. However, this mode of therapy appears to have promise for improving the cost-effectiveness of treatment for chronic VLUs.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Marston WA, Kirsner RS, Tallis A, et al. Economic benefit of a novel dual-mode ambulatory compression device for treatment of chronic venous leg ulcers in a randomized clinical trial. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32451241. doi:10.1016/j.jvsv.2020.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。